申请人:ENVIVO PHARMACEUTICALS INC
公开号:WO2013142269A1
公开(公告)日:2013-09-26
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9 and pharmaceutically acceptable salt thereof. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.
本发明提供了咪唑三唑酮化合物,它们是磷酸二酯酶9的抑制剂及其药用盐。本发明还提供了用于治疗哺乳动物,包括人类,PDE9相关疾病或疾病的过程、药物组成、药物制剂和化合物的药用。